AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 80 filers reported holding AVADEL PHARMACEUTICALS PLC in Q1 2021. The put-call ratio across all filers is 0.96 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $100,000 | -15.3% | 14,569 | 0.0% | 0.02% | +15.4% |
| Q4 2021 | $118,000 | -78.5% | 14,569 | -74.0% | 0.01% | -81.7% |
| Q3 2021 | $549,000 | -24.2% | 56,069 | -47.9% | 0.07% | -12.3% |
| Q2 2021 | $724,000 | +86.1% | 107,620 | +150.0% | 0.08% | +113.2% |
| Q1 2021 | $389,000 | -36.9% | 43,051 | -53.3% | 0.04% | -30.9% |
| Q4 2020 | $616,000 | +32.5% | 92,224 | 0.0% | 0.06% | +31.0% |
| Q3 2020 | $465,000 | -20.4% | 92,224 | +27.7% | 0.04% | -30.0% |
| Q2 2020 | $584,000 | +4.1% | 72,224 | +2.2% | 0.06% | -17.8% |
| Q1 2020 | $561,000 | +85.8% | 70,673 | +76.7% | 0.07% | +121.2% |
| Q4 2019 | $302,000 | – | 40,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WEALTH EFFECTS LLC | 2,305,017 | $18,625,000 | 7.73% |
| COWEN AND COMPANY, LLC | 3,732,778 | $30,161,000 | 2.74% |
| GENDELL JEFFREY L | 2,446,299 | $19,766,000 | 1.60% |
| Asymmetry Capital Management, L.P. | 369,134 | $2,983,000 | 1.58% |
| Vivo Capital, LLC | 2,937,093 | $23,732,000 | 1.43% |
| Samsara BioCapital, LLC | 659,409 | $5,328,000 | 1.03% |
| Altium Capital Management LP | 440,589 | $3,560,000 | 0.98% |
| Knott David M Jr | 258,198 | $2,086,000 | 0.71% |
| RTW INVESTMENTS, LP | 5,741,939 | $46,395,000 | 0.68% |
| FRAZIER MANAGEMENT LLC | 951,814 | $7,691,000 | 0.59% |